| __timestamp | Teva Pharmaceutical Industries Limited | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1488000000 | 396000000 |
| Thursday, January 1, 2015 | 1525000000 | 364000000 |
| Friday, January 1, 2016 | 2111000000 | 376000000 |
| Sunday, January 1, 2017 | 1848000000 | 382000000 |
| Monday, January 1, 2018 | 1213000000 | 432000000 |
| Tuesday, January 1, 2019 | 1010000000 | 457000000 |
| Wednesday, January 1, 2020 | 997000000 | 463000000 |
| Friday, January 1, 2021 | 967000000 | 508000000 |
| Saturday, January 1, 2022 | 838000000 | 539000000 |
| Sunday, January 1, 2023 | 953000000 | 614000000 |
| Monday, January 1, 2024 | 998000000 | 686000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Zoetis Inc. and Teva Pharmaceutical Industries Limited have showcased contrasting trends in their R&D investments. From 2014 to 2023, Teva's R&D expenses have seen a significant decline of approximately 36%, dropping from their peak in 2016. In contrast, Zoetis has steadily increased its R&D spending by around 55% over the same period, reflecting a strategic focus on innovation.
Teva's highest R&D expenditure was in 2016, while Zoetis reached its peak in 2023. This divergence highlights Zoetis's commitment to growth and adaptation in a rapidly evolving market. As the pharmaceutical landscape continues to change, these spending patterns may offer insights into each company's future trajectory and market positioning.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development: Comparing Key Metrics for Novartis AG and Zoetis Inc.
Analyzing R&D Budgets: Amgen Inc. vs Zoetis Inc.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Zoetis Inc. and Teva Pharmaceutical Industries Limited: A Detailed Gross Profit Analysis
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Zoetis Inc. vs Dynavax Technologies Corporation
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds